C4 Therapeutics, Inc.CCCCNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Under Pressure
Below historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
-18.92%
↓ 1159% below average
Average (26q)
-1.50%
Historical baseline
Range
High:91.27%
Low:-107.69%
Volatility
-13237.8%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -18.92% |
| Q2 2025 | 0.00% |
| Q1 2025 | 24.49% |
| Q4 2024 | -40.00% |
| Q3 2024 | -34.62% |
| Q2 2024 | 36.59% |
| Q1 2024 | 39.71% |
| Q4 2023 | -23.64% |
| Q3 2023 | 24.66% |
| Q2 2023 | -5.80% |
| Q1 2023 | 6.76% |
| Q4 2022 | -15.62% |
| Q3 2022 | -14.29% |
| Q2 2022 | 15.15% |
| Q1 2022 | -106.25% |
| Q4 2021 | 37.25% |
| Q3 2021 | 0.00% |
| Q2 2021 | -4.08% |
| Q1 2021 | 7.55% |
| Q4 2020 | 1.85% |
| Q3 2020 | -107.69% |
| Q2 2020 | 62.32% |
| Q1 2020 | -18.97% |
| Q4 2019 | 1.69% |
| Q3 2019 | 91.27% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |